Clinical Trials Browser

Phase 2/3 × Mitoxantrone × Genitourinary × Clear all

NCT03258320 2026-01-12

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Phase 2/3 Recruiting

Prostatic Neoplasms

NCT00004071 2012-09-11

Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer

Phase 2/3 Completed

Prostatic Neoplasms